The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma

• Main Authors: Jian Huang (Author), Wang Liu (Author), Shiqi Song (Author), Jean C. Li (Author), Kaimei Gan (Author), Chunxiao Shen (Author), Jeffrey Holzbeierlein (Author), Benyi Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Reliable biomarkers are rare for renal cell carcinoma (RCC) treatment selection. We aimed to discover novel biomarkers for precision medicine. The iron-regulating hormone hepcidin (HAMP) was reportedly increased in RCC patient sera and tissues. However, its potential implication as a pro...